000			02792na a2200481 4500
999			_c6614 _d6614
003			PC6614
005			20210423142644.0
008			130622s2014 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aCarreira Delgado, Patricia Esmeralda _9467 _eReumatología
245	0	0	_aPrevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study. _h[artículo]
246			_aPrevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis
260			_bThe Journal of rheumatology, _c2014
300			_a41(1):99-105.
500			_aFormato Vancouver: Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol. 2014 Jan;41(1):99-105.
501			_aPMID: 24293584
504			_aContiene 30 referencias
520			_aObjective. To estimate the prevalence, determine the subgroups at risk, and the outcomes of patients with systemic sclerosis (SSc) and gastric antral vascular ectasia (GAVE). Methods. We queried the European League Against Rheumatism Scleroderma Trials and Research (EUSTAR) network for the recruitment of patients with SSc-GAVE. Each case was matched for cutaneous subset and disease duration with 2 controls with SSc recruited from the same center, evaluated at the time the index case made the diagnosis of GAVE. SSc characteristics were recorded at the time GAVE occurred and the last observation was collected to define the outcomes.
710			_9123 _aServicio de Reumatología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6614.pdf _ySolicitar documento
942			_n0 _2ddc _cART